Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
176M
-
Number of holders
-
36
-
Total 13F shares, excl. options
-
63.9M
-
Shares change
-
+3.58M
-
Total reported value, excl. options
-
$146M
-
Value change
-
+$8.15M
-
Number of buys
-
19
-
Number of sells
-
-6
-
Price
-
$2.28
Significant Holders of Compass Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CMPX) as of Q3 2022
39 filings reported holding CMPX - Compass Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q3 2022.
Compass Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CMPX) has 36 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 63.9M shares
of 176M outstanding shares and own 36.2% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (22M shares), FMR LLC (6.35M shares), Rock Springs Capital Management LP (5.33M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (4.61M shares), Foresite Capital Management V, LLC (4.4M shares), JANUS HENDERSON GROUP PLC (3.52M shares), CHI Advisors LLC (2.83M shares), VANGUARD GROUP INC (2.38M shares), Avidity Partners Management LP (2M shares), and Vivo Capital, LLC (2M shares).
This table shows the top 36 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.